Investor Presentaiton
Steady Sales growth of 7%
(3-year CAGR 9%); Sales
growth, excluding hygiene in
Indonesia, at 10%
Consolidated 7% (8% CC)
Sales growth
3-year CAGR 9% (9% CC)
India
Sales growth 8%
3-year CAGR 9%
Consolidated EBITDA growth (15)%
1
Underlying Volume Growth:
Consolidated -5% year-on-year; 3-year CAGR 1%
Standalone -5% year-on-year; 3-year CAGR 1%
2 Steady growth in India 8% (3-year CAGR 9%),
Africa, USA & Middle East 13% CC (3-year CAGR 13%)
and Latin America & SAARC 34% CC (3-year CAGR 30%);
Indonesia (11)% CC (3-year CAGR -4%);
Indonesia growth ex-hygiene 8% CC
3
Consolidated EBITDA margins at 17.1% (15%
degrowth); margins decrease by 450 bps year-on-year
EBITDA + working media margins decrease 200 bps (1% degrowth)
Quality of profits improving, driven by sequential recovery in Gross Margin; witnessed lower year-on-year drop in Gross Margin
sequentially (decreased by 200 bps in Q2FY23 from 560 bps in Q1FY23). In line with our strategy to drive category development,
significant increase in working media investment (increased by 250 bps; 69% growth).
Note: CC Constant Currency
LO
5View entire presentation